시장보고서
상품코드
1320172

세계의 감마 나이프 시장 : 질병 적응별, 해부학별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Gamma Knife Market with COVID-19 Impact Analysis, By Disease Indications, By Anatomy, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 312 Pages | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

감마 나이프(Gamma Knife) 시장 규모는 2022년 4억 8,090만 달러였으며, 2023년부터 2030년까지 CAGR 5.3%로 추이하며 확대될 것으로 예상됩니다.

감마 나이프 시장 - 시장 역학 :

비침습성 및 최소한의 부작용, 인지도 및 수용성, 기술 진보가 시장 성장을 가속

감마 나이프 절차는 개복 수술이 필요하지 않으며 비 침습적입니다. 또한 집중된 방사선 빔을 사용하여 주변의 건강한 조직을 보존하면서 특정 뇌 영역을 표적으로 삼고 치료합니다. 기존 수술 방법에 비해 부작용과 합병증 위험을 줄여 환자에게 특별한 옵션이 될 수 있습니다. 또한 감마 나이프 수술의 장점에 대한 의료진과 환자 전문가들의 인식이 높아지면서 감마 나이프 수술에 대한 관심이 높아지고 있습니다. 감마 나이프의 안전성과 효능을 뒷받침하는 임상 증거가 늘어나면서 전 세계적으로 이 기술의 수용과 사용이 증가하고 있습니다. 그러나 제품 제조에 드는 높은 비용과 적절한 인프라 부족은 시장 성장을 저해할 것으로 예상됩니다. 또한 감마 나이프 기술의 지속적인 발전은 시장 성장의 기회를 제공합니다. 이에 따라 제조업체는 치료 계획 소프트웨어, 이미징 기능 개선 및 방사선 전달 시스템에 집중하여 효율성, 정밀도 및 환자 결과를 개선 할 수 있습니다. 또한 보다 다재다능하고 컴팩트한 시스템을 개발하여 감마 나이프 기술의 적용 가능성을 확대할 수 있습니다. 이러한 요인들이 감마 나이프 시장 수요를 견인할 것으로 예상됩니다.

감마 나이프 시장 - 주요 통찰 :

  • 우리의 연구 분석가가 공유한 분석에 따르면, 세계의 감마 나이프 시장은 예측 기간(2023-2030년)에 약 5.3%의 CAGR로 매년 성장할 것으로 예측됩니다.
  • 감마 나이프 산업은 의료 및 환자 전문가의 의식이 높아짐에 따라 큰 성장률로 성장할 것으로 예상됩니다.
  • 시장 세분화에 따르면 2022년 시장에서는 암이 가장 큰 점유율을 차지했습니다.
  • 해부학적 세분화에 기초하여, 머리는 2022년의 주요 유형이었습니다.
  • 지역별로는 북미가 2022년에 수익을 창출하는 주요 시장이 됩니다.

감마 나이프 시장 - 세분화 분석 :

세계의 감마 나이프 시장은 적응 질환, 해부학적 구조, 최종 사용자 및 지역에 따라 세분화됩니다.

적응 질환에 따라 암, 안구 질환, 뇌 전이, 혈관 장애, 기능 장애, 운동 장애, 삼차 신경통, 동정맥 기형 (AVM) 및 기타의 8가지 범주로 나뉩니다. 암 부문은 새로운 암 사례와 암 사망으로 인해 예측 기간 동안 시장을 지배 할 것으로 예상됩니다. 또한이 경우 기억해야 할 필수 사항은 시장의 특정 부분이 뇌암으로 구성되어 있다는 것입니다. 또한 환자의 암이 4단계로 극복되면 환자의 뇌에 영향을 미쳤을 가능성이 상당히 높습니다. 따라서 이러한 요소는 성장 증가에 기인합니다.

시장은 해부학적 구조에 따라 경부, 머리, 기타 등 여러 범주로 분류됩니다. 머리 부문은 시장에서 우위를 유지할 가능성이 높습니다. 머리의 깊은 종양을 효과적이고 비 침습적으로 치료할 수 있다는 것은이 분야 수요를 뒷받침합니다. 게다가 신경외과 수술은 환자의 안전에 큰 위험을 초래하기 때문에 머리의 심부 종양과 암은 감마 나이프 치료가 주류가 됩니다.

시장은 최종 사용자에 의해 외래 서비스 센터, 병원, 클리닉의 세 가지로 분류됩니다. 시장 세분화에서는 병원 부문이 가장 큰 판매 점유율을 차지할 것으로 보입니다. 헬스케어 분야에서는 기술 진보 증가가 이 분야의 성장을 추진할 것으로 예상됩니다. 또한, 컴퓨터 유도 치료인 감마 나이프 과정은 외과의사가 최고 수준의 정확도로 절차를 수행할 수 있도록 합니다. 이는 영상처리 소프트웨어의 이용을 촉진하는 한편 시장 점유율의 급상승에 기여하고 있습니다.

감마 나이프 시장 - 지역적 통찰력 :

지역적으로, 이 시장은 북미, 남미, 유럽, 아시아 태평양 및 중동 및 아프리카의 각 지역으로 퍼져 있습니다. 이 지역은 비즈니스를 제공하는 국가에 따라 더욱 세분화됩니다.

감마 나이프 시장 - 경쟁 구도 :

감마 나이프 시장은 신경 질환의 이환율이 증가함에 따라 꾸준히 확대됩니다. 또한 세계의 감마 나이프 시장은 R&D 활동 확대, 협업, 신제품 출시에 의해 견인됩니다. 시장의 급성장을 뒷받침하는 주요 요소 중 하나는 기술, 가용성, 제품 비용, 성능 등 주요 시장 기업의 전략적 노력입니다. 또한 경쟁 우위를 확보하기 위해 주요 기업은 제품 라인업을 확대하고 있습니다. 예를 들어, 렉셀 감마플랜은 렉셀 감마나이프와 완벽하게 호환되는 고급 치료 계획 및 관리 소프트웨어로, 특히 두개내 방사선 수술 요건을 충족하도록 설계되었습니다. 또한 시스템에 구현된 첨단 기술을 완벽하게 활용하는 동시에 효율적이고 안전한 치료 워크플로우를 보장하는 특정 도구를 제공합니다.

최근 동향

예를 들어, 2022년 10월 Varian과 신시내티 아동/대학은 양성자 플래시의 인체 최초 경험이자 초고선량률 플래시 치료의 첫 임상시험인 FAST-01(증상성 골 전이 치료를 위한 플래시 방사선 치료의 타당성 연구)의 임상시험 결과를 발표했습니다.

연구의 주요 특징

  • 감마 나이프 시장 시장 규모, 연간 평균 성장률(CAGR%), 2022년을 기준으로 한 추정 및 예측(2023-2030년)을 제공합니다.
  • 감마 나이프 시장에 대한 최신 동향에 대한 통찰력을 고객에게 제공합니다.
  • 다양한 부문/국가에 걸친 잠재적인 성장 기회를 설명하고 감마 나이프 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
  • 신규 투자 기회, 기존 기업이 직면한 과제, 감마 나이프 시장에서 지속하기 위한 성장 요인을 확인합니다.
  • COVID-19가 감마 나이프 시장 규모, 예측, CAGR, 시장 역학에 미치는 영향에 대해서는 조사 범위에서 자세히 논의합니다. COVID-19 이후 감마 나이프 시장에 대한 자세한 통찰력도 다룹니다.
  • 사용자에게 감마 나이프 시장의 종합적인 견해를 제공하기 위해 감마 나이프 시장 경쟁 구도와 주요 혁신자 분석을 포함합니다.
  • 시장 규모, 성장률 및 매력에 따라 모든 산업 부문을 벤치마킹하는 성장 전망 매핑 분석을 다룹니다.
  • 감마 나이프 시장에서 사업을 전개하는 기업의 재무 정보와 전략적 이니셔티브를 이해하는 데 도움이되는 주요 시장 진출 기업을 특징으로하는 상세한 기업 개요를 제공합니다.
  • 또한 세계의 수준뿐만 아니라 지역 수준에서 시장에 참여하는 주요 진출기업의 중요한 인수 및 합병, 제휴 및 조인트 벤처, 신규 출시, 연구 개발, 지역 확대에 대해서도 밝히고 있습니다.
  • 감마 나이프 시장 보고서는 주로 공급업체, 투자자, 신규 참여자, 유통업체, 금융 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.

목차

제1장 감마 나이프 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 감마 나이프 주요 시장 동향

  • 감마 나이프 시장 성장 촉진 요인
  • 감마 나이프 시장 성장 억제 요인
  • 감마 나이프 시장 기회
  • 감마 나이프 시장 향후 동향

제4장 감마 나이프 산업 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 프레임워크 분석

제5장 감마 나이프 시장 : COVID-19 영향 분석

  • COVID-19 이전 영향 분석
  • COVID-19 이후 영향 분석

제6장 감마 나이프 시장 상황

  • 감마 나이프 시장 점유율 분석(2022년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 감마 나이프 시장 - 질환 적응별

  • 개요
    • 질병 적응별 부문 점유율 분석
    • 안질환
    • 뇌전이
    • 혈관 장애
    • 기능장애
    • 운동장애
    • 삼차 신경통
    • 동정맥 기형(AVM)
    • 기타

제8장 감마 나이프 시장 - 해부학별

  • 개요
    • 해부학별 부문 점유율 분석
    • 머리
    • 기타

제9장 감마 나이프 시장 - 최종 사용자별

  • 개요
    • 최종 사용자별 부문 점유율 분석
    • 외래 서비스 센터
    • 병원
    • 클리닉

제10장 감마 나이프 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 감마 나이프 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 감마 나이프 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아 태평양(APAC)
    • 개요
    • 아시아 태평양의 감마 나이프 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 남미
    • 개요
    • 남미의 감마 나이프 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 감마 나이프 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석-감마 나이프 산업

  • 경쟁 대시보드
  • 기업 개요
    • American Shared Hospital Services
    • Hitachi, Ltd.
    • Brainlab
    • GENERAL ELECTRIC COMPANY
    • Elekta AB
    • BondWellOrtho
    • Ono Sokki India Private Limited.
    • Blount Memorial Hospital
    • Panacea Medical Technologies Pvt. Ltd.
    • American Radiosurgery Inc.
    • UT Health East Texas.
    • MASEP
    • UT Health East Texas.

제12장 애널리스트의 전방위 전망

LYJ 23.08.21

REPORT HIGHLIGHT

Gamma knife market size was valued at USD 480.9 Million in 2022, expanding at a CAGR of 5.3% from 2023 to 2030.

The gamma knife market is defined as the global market for gamma knife-related products & services and radiosurgery systems. Additionally, it is a non-invasive surgical technology utilized in the treatment of several neurological conditions, primarily other brain disorders. Moreover, it involves highly focused radiation beams to precisely target and treat certain areas of the brain while reducing damage to healthy surrounding tissues.

Gamma Knife Market- Market Dynamics:

Non-invasiveness & minimal side effects, awareness & acceptance, and technological advancement will boost the market growth

The Gamma Knife procedure does not require open surgery and it is non-invasive. In addition, it uses focused radiation beams to target and treat specific brain areas while sparing surrounding healthy tissues. It reduces side effects and the risk of complications over traditional surgical methods, making it a unique option for patients. Moreover, the benefits of Gamma Knife surgery are attributed to a growing awareness among healthcare and patient professionals. The acceptance and use of this technology are increasing globally as more clinical evidence supports its safety and efficacy. However, the product manufacturing high cost and lack of suitable infrastructure are expected to obstruct market growth. Furthermore, in gamma knife technology continued advancements present opportunities for market growth. In line with this, manufacturers can focus on treatment planning software, improving imaging capabilities, and radiation delivery systems to improve efficiency, precision, and patient outcomes. The applicability of Gamma Knife technology could also be expanded by developing more versatile and compact systems. This, in turn, such factors projected to drive the gamma knife market demand.

Gamma Knife Market- Key Insights:

  • As per the analysis shared by our research analyst, the global gamma knife market is estimated to grow annually at a CAGR of around 5.3% over the forecast period (2023-2030)
  • The gamma knife industry is projected to grow at a significant rate due to the growing awareness among healthcare and patient professionals
  • Based on indications segmentation, cancer was predicted to show maximum market share in the year 2022
  • Based on anatomy segmentation, head was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Gamma Knife Market- Segmentation Analysis:

The global gamma knife market is segmented on the basis of disease indications, anatomy, end user, and region.

The market is divided into eight categories based on disease indications: cancer, ocular diseases, brain metastasis, vascular disorders, functional disorders, movement disorders, trigeminal neuralgia, arteriovenous malformation (AVM), and others. The cancer segment is expected to dominate the market over the forecast period owing to the new cancer cases and cancer death. Additionally, in this case, an essential thing to remember is a particular portion of the market is made up of brain cancer. Moreover, when a patient's cancer is surmounted to stage four, there is a considerable possibility that it has affected the patient's brain. Thus, these elements are attributed to increasing segment growth.

The market is divided into two categories based on anatomy: neck, head, and others. The head segment is likely to maintain its dominance in the market. The effective and the non-invasive treatment of deep tumors in the head using this method, owing to such factors propelling the segment demand. Additionally, neurosurgery poses a great risk to the safety of the patient, thus deep tumors or cancer in the head is majorly done by gamma knife treatment.

The market is divided into three categories based on end-users: ambulatory service centers, hospitals, and clinics. The hospital segment is likely to possess the largest revenue share in the market. In the healthcare sector, the increasing technological advancement is expected to surge segment growth. Moreover, as a computer-guided treatment, the gamma knife process enables surgeons to perform the procedure at the highest level of accuracy. This is attributed to the surge in the market share while also promoting the utilization of imaging software.

Gamma Knife Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Gamma Knife Market- Competitive Landscape:

The gamma knife market is rising steadily owing to the increasing incidence of neurological disorders. Moreover, the global gamma knife market is driven by growing R&D activities, collaboration, and new product launches. One of the main elements fueling the market's rapid rise is strategic initiatives by the key market players including technology, availability, product cost, and performance. Furthermore, to acquire a competitive advantage key players are expanding their product offerings. For instance, Leksell GammaPlan is advanced treatment planning and management software that is fully compatible with Leksell Gamma Knife and is particularly designed to meet intracranial radiosurgery requirements. Additionally, it offers certain tools that make complete use of the advanced technology implemented into the system while ensuring efficient and safe treatment workflows.

Recent Developments:

For instance, in October 2022, Varian and Cincinnati Children's/University announced clinical trial results from FAST-01 (FeAsibility Study of Flash Radiotherapy for the Treatment of Symptomatic Bone Metastases), the first-in-human experience of proton Flash and the first clinical trial of ultra-high dose rate Flash therapy.

Key features of the study:

  • This proposed research study on gamma knife market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the gamma knife market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for gamma knife market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the gamma knife market.
  • Impact of COVID-19 on gamma knife market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on gamma knife market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the gamma knife market, we have also included competitive landscape and key innovator analysis for the gamma knife market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the gamma knife market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global gamma knife market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GAMMA KNIFE MARKET KEY PLAYERS

  • American Shared Hospital Services
  • Hitachi, Ltd.
  • Brainlab
  • GENERAL ELECTRIC COMPANY
  • Elekta AB
  • BondWellOrtho
  • Ono Sokki India Private Limited.
  • Blount Memorial Hospital
  • Panacea Medical Technologies Pvt. Ltd.
  • American Radiosurgery Inc.
  • UT Health East Texas.
  • MASEP
  • UT Health East Texas.

GLOBAL GAMMA KNIFE MARKET, BY DISEASE INDICATIONS

  • Cancer
  • Ocular Diseases
  • Brain Metastasis
  • Vascular Disorders
  • Functional Disorders
  • Movement Disorders
  • Trigeminal Neuralgia
  • Arteriovenous Malformation (AVM)
  • Others

GLOBAL GAMMA KNIFE MARKET, BY ANATOMY

  • Neck
  • Head
  • Others

GLOBAL GAMMA KNIFE MARKET, BY END USER

  • Ambulatory Service Centers
  • Hospitals
  • Clinics

GLOBAL GAMMA KNIFE MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Gamma Knife Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Gamma Knife Market Snippet by Disease Indications
    • 2.1.2. Gamma Knife Market Snippet by Anatomy
    • 2.1.3. Gamma Knife Market Snippet by End User
    • 2.1.4. Gamma Knife Market Snippet by Country
    • 2.1.5. Gamma Knife Market Snippet by Region
  • 2.2. Competitive Insights

3. Gamma Knife Key Market Trends

  • 3.1. Gamma Knife Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Gamma Knife Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Gamma Knife Market Opportunities
  • 3.4. Gamma Knife Market Future Trends

4. Gamma Knife Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Gamma Knife Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Gamma Knife Market Landscape

  • 6.1. Gamma Knife Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Gamma Knife Market - By Disease Indications

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Indications, 2022&2030 (%)
    • 7.1.2. Cancer
    • 7.1.3. Ocular Diseases
    • 7.1.4. Brain Metastasis
    • 7.1.5. Vascular Disorders
    • 7.1.6. Functional Disorders
    • 7.1.7. Movement Disorders
    • 7.1.8. Trigeminal Neuralgia
    • 7.1.9. Arteriovenous Malformation (AVM)
    • 7.1.10. Others

8. Gamma Knife Market - By Anatomy

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Anatomy, 2022&2030 (%)
    • 8.1.2. Neck
    • 8.1.3. Head
    • 8.1.4. Others

9. Gamma Knife Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022&2030 (%)
    • 9.1.2. Ambulatory Service Centers
    • 9.1.3. Hospitals
    • 9.1.4. Clinics

10. Gamma Knife Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Gamma Knife Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Gamma Knife Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Gamma Knife Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Gamma Knife Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Gamma Knife Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Indications, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Anatomy, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Gamma Knife Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. American Shared Hospital Services
    • 11.2.2. Hitachi, Ltd.
    • 11.2.3. Brainlab
    • 11.2.4. GENERAL ELECTRIC COMPANY
    • 11.2.5. Elekta AB
    • 11.2.6. BondWellOrtho
    • 11.2.7. Ono Sokki India Private Limited.
    • 11.2.8. Blount Memorial Hospital
    • 11.2.9. Panacea Medical Technologies Pvt. Ltd.
    • 11.2.10. American Radiosurgery Inc.
    • 11.2.11. UT Health East Texas.
    • 11.2.12. MASEP
    • 11.2.13. UT Health East Texas.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제